Lysalgo en es it fr

Lysalgo Brand names, Lysalgo Analogs

Lysalgo Brand Names Mixture

  • No information avaliable

Lysalgo Chemical_Formula


Lysalgo RX_link

Lysalgo fda sheet

Lysalgo msds (material safety sheet)

Lysalgo MSDS

Lysalgo Synthesis Reference

No information avaliable

Lysalgo Molecular Weight

241.285 g/mol

Lysalgo Melting Point

230-231 oC

Lysalgo H2O Solubility

20 mg/L

Lysalgo State


Lysalgo LogP


Lysalgo Dosage Forms

Bolus; Capsule; Capsule (enteric-coated); Drops; Liquid; Lotion; Powder; Powder for solution; Shampoo; Soap bar; Solution; Stick; Syrup; Tablet; Tablet (extended-release)

Lysalgo Indication

For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.

Lysalgo Pharmacology

Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.

Lysalgo Absorption

Mefenamic acid is rapidly absorbed after oral administration.

Lysalgo side effects and Toxicity

Oral, rat LD50: 740 mg/kg. Symptoms of overdose may include severe stomach pain, coffee ground-like vomit, dark stool, ringing in the ears, change in amount of urine, unusually fast or slow heartbeat, muscle weakness, slow or shallow breathing, confusion, severe headache or loss of consciousness.

Lysalgo Patient Information

Lysalgo Organisms Affected

Humans and other mammals